LLY compared with ZVRA: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

ZVRAZevra Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

ZVRAZevra Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

ZVRA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±18.2%▲+8.87%×0.49

Q2 FY26±13.4%▲+12.82%×0.96

= impliedLLY realized, solidZVRA realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedSource: market data

May 7 '26

±13.3%

▼−2.22%

×0.17

Q1 FY26±29.2%▲+21.27%×0.73

LLYELI Lilly & Co

1,396.95▲+3.17%

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

ZVRAZevra Therapeutics, Inc.

11.64▲+0.46%

Regular sessionNov 9 '26

Mkt cap$689.7MRevenue$38MQ3 FY26Revenue$106MFY25

Compare

Regular sessionNov 9 '26

LLYELI Lilly & Co

ZVRAZevra Therapeutics, Inc.

1,396.95▲+3.17%

Price

11.64▲+0.46%

$1.2T

Mkt cap

$689.7M

Q3 FY26$24.4B

Revenue

$38MQ3 FY26

FY25$65.2B

Revenue

$106MFY25

LLY1,396.95▲+3.17%vsZVRA11.64▲+0.46%Regular sessionNov 9 '26